On Remand From En Banc Court, Federal Circuit Panel Affirms Noninfringement Ruling
WASHINGTON, D.C. — In a Feb. 6 decision, the Federal Circuit U.S. Court of Appeals agreed with a Delaware federal judge that two patents relating to the injectable bivalirudin drug Angiomax...To view the full article, register now.
Already a subscriber? Click here to view full article